Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
- for people ages 18 years and up (full criteria)
- at UCSD
- study startedestimated completion
Open-Angle Glaucoma Ocular Hypertension Glaucoma Glaucoma, Open-Angle Hypertension Bimatoprost Bimatoprost SR Bimatoprost SR 10mcg; Lead-in study 192024-093 Bimatoprost SR 15mcg; Lead-in studies 192024-093/-095 Bimatoprost SR 10mcg; Lead-in studies 192024-091/-092 Bimatoprost SR 15mcg; Lead-in studies 192024-091/-092
- accepting new patients by invitation only
- Start Date
- Completion Date
- Additional information on study locations near you may be found at AllerganClinicalTrials.com. For any study not on AllerganClinicalTrials.com, please contact IR-CTRegistration@Allergan.com for assistance.
- To be considered as a site for current and future Allergan Clinical Trials, please register using the Investigator Databank link.
- Phase 3
- Study Type
- Last Updated